BICYCLE THERAPEUTICS LTD reports a Return on Equity (ROE) of -39.51%.

What is BCYC's dividend yield?

BICYCLE THERAPEUTICS LTD offers a dividend yield of 0.00%.

What is BCYC's Deepscope Quality Score?

Deepscope rates BCYC's overall financial quality at 8 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy BCYC?

Deepscope's AI Timing Score for BCYC is 26 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

Which sector does BCYC belong to?

BICYCLE THERAPEUTICS LTD is classified under the Healthcare >> Biotechnology sector on the NASDAQ exchange.

Cổ phiếu BCYC (NASDAQ) | BICYCLE THERAPEUTICS LTD

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-12 | FS: 2026-03-31)

BCYC

BICYCLE THERAPEUTICS LTD

US:NASDAQ STOCK Healthcare >> Biotechnology News 79

USD 4.05

-0.05 (-1.22%) Day Change

Watchlist Portfolio Compare Chart

0.18

D/E

-39.5%

ROE

-33.6%

ROA

0.00%

Div Yield

BICYCLE THERAPEUTICS LTD
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 4.05 Price -0.05 (-1.22%) Day Change	NEWS SCORE: 79

BCYC Chất lượng tổng thể của cố phiếu Không tốt ( Chất lượng = 8) và Thời điểm mua ...(Sign In to See)...

Loading chart...

8 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: Tỷ lệ ROE tương đối thấp
Tỷ lệ ROA tương đối thấp
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Lịch sử ROE tương đối thấp
Tăng trưởng ROE là âm trong năm ngoái.
ROE đang giảm đáng kể
ROA quá thấp so với ROE
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tăng trưởng ROA hiện tại đang dưới mức tiêu chí của chúng tôi.
Biên lợi nhuận ròng tương đối thấp.
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
Lịch sử Biên lợi nhuận ròng tương đối thấp.

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Không tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Không tốt , ...

Yếu tố Chất lượng

48%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	79
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	4.05
PBV / Sector	0.52 / 4.91 GREAT
Earning Per Share	-3.10

PE / Sector	N/A / 18.34
PEG or PE/Growth / Sector	N/A / 0.61
Average 1M Daily Value	1.51 M GREAT
Average 1W Daily Value	2.12 M GREAT

Yếu tố Kỹ thuật

42%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Sức khỏe tài chính

50%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

Khả năng kiếm lợi nhuận

43%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	-344.95 / 468.85
NPM Average (%) / Sector	-514.97 / -1,531.69
NPM Change Average (%) / Sector	-16.30 / 5,028.65
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-33.57 / 31.69
ROA Average (%) / Sector	-27.91 / -353.18
ROA Change Average (%) / Sector	12.88 / 5,214.65 GOOD
ROE (%) / Sector	-39.51 / 10.58
ROE Average (%) / Sector	-37.41 / 27.64
ROE Change Average (%) / Sector	9.82 / 2,048.88
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

Lợi tức cho nhà đầu tư

Dividend (%) / Sector	N/A / 0.05
Dividend Average (%) / Sector	N/A / 16.49
Dividend Change Average (%) / Sector	N/A / 5.15

Chi tiết đăng ký

Analyze Date	2026-06-13 11:13:22
Symbol	BCYC
Name	BICYCLE THERAPEUTICS LTD
Sector	Healthcare >> Biotechnology
Market	NASDAQ
Listed Shares	50.37 M
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	286.23 / 9,034.83

Tin tức, Dự báo ước tính

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: Portway Building, Cambridge, United Kingdom, CB21 6GS

Phone: 44 1223 261 503

Website: https://www.bicycletherapeutics.com

Employees: 288

Sector: Healthcare >> Biotechnology

Description: Bicycle Therapeutics plc, a clinical-stage pharmaceutical company, develops a class of medicines for diseases that are underserved by existing therapeutics in the United States and the United Kingdom. The company's products pipeline include zelenectide pevedotin, a bicycle toxin conjugate (BTC), which is in phase II clinical trials for the treatment of high nectin-4 expressing tumors; nuzefatide pevedotin (EphA2), a BTC that is in phase I/II clinical trials to treat Ephrin type A receptor 2 expressing tumor; BT7480, a Bicycle tumor-targeted immune cell agonist molecule, which is in phase I/II targeting nectin-4 and agonizing CD137; and BT1702, a theranostic BRC molecule targeting MT1-MMP for which IND-enabling activities are ongoing. In addition, it develops Novel CNS targets, which is in preclinical trial targeting CNS disease; Novel neuromuscular targets, which is in preclinical trial targeting neuromuscular disease; and programs that are in preclinical trial targeting radiopharmaceutical. Further, the company collaborates with biopharmaceutical companies and organizations to develop programs in therapeutic areas. It has collaboration and license agreement with Bayer Consumer Care AG; Novartis Pharma AG; Ionis Pharmaceuticals, Inc.; Genentech, Inc; and AstraZeneca AB. Bicycle Therapeutics plc was incorporated in 2009 and is headquartered in Cambridge, the United Kingdom.